Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001378790 | SCV001576446 | pathogenic | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | This variant, c.7990_7992del, results in the deletion of 1 amino acid(s) of the CDH23 protein (p.Phe2664del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs774559018, gnomAD 0.003%). This variant has been observed in individual(s) with nonsyndromic deafness (PMID: 21940737). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 996634). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473848 | SCV004212279 | likely pathogenic | Pituitary adenoma 5, multiple types | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005040132 | SCV005677024 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 12; Usher syndrome type 1D; Pituitary adenoma 5, multiple types | 2024-04-26 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV001291221 | SCV001479646 | likely pathogenic | Hearing loss, autosomal recessive | no assertion criteria provided | research | ||
Natera, |
RCV001836256 | SCV002088762 | likely pathogenic | Usher syndrome type 1 | 2020-03-24 | no assertion criteria provided | clinical testing |